See more : Mohit Paper Mills Limited (MOHITPPR.BO) Income Statement Analysis – Financial Results
Complete financial analysis of Zeon Corporation (ZEOOF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Zeon Corporation, a leading company in the Chemicals – Specialty industry within the Basic Materials sector.
- Sentelic Corporation (4945.TWO) Income Statement Analysis – Financial Results
- Topsec Technologies Group Inc. (002212.SZ) Income Statement Analysis – Financial Results
- DraftKings Inc. (DKNG) Income Statement Analysis – Financial Results
- Voyageur Mineral Explorers Corp. (VOY.CN) Income Statement Analysis – Financial Results
- Seoul Food Industrial.Co.,Ltd (004415.KS) Income Statement Analysis – Financial Results
Zeon Corporation (ZEOOF)
About Zeon Corporation
Zeon Corporation engages in the elastomers, specialty materials, and other businesses. The company offers synthetic rubbers, such as general-purpose rubbers for use in automobile tire applications; and various specialty rubbers, including NBR and hydrogenated NBR. It also provides synthetic latex comprising styrene-butadiene copolymer latex, polybutadiene, acrylonitrile butadiene copolymer latex, acrylate latex, and soap-free latex for use in processed paper, fiber treatment agents, adhesives, paints, and rubber gloves; and materials for adhesive tapes and hot melt adhesives, binder for traffic paints, and concrete admixtures. In addition, the company offers specialty chemicals, such as synthetic aroma chemicals for flavors and fragrances; cyclopentene, cyclopentanone, and other derivatives for chemical synthesis; intermediates for pharmaceuticals and agrochemicals; and solvents and cleaning agents. Further, it provides electronic materials, rechargeable battery materials, and toners for the production of semiconductors, etching gas, and materials used in rechargeable battery production; and specialty plastics that include cyclo olefin polymers and fine processed products with cyclo olefin polymer for use in optical lenses, medical devices, and various general-purpose engineering plastics. Additionally, the company develops, manufactures, and sells cardiovascular and gastrointestinal medical equipment, as well as nutritional products; and licenses butadiene recovery and butene purification process technologies in approximately 23 countries worldwide. It also offers PENTAM, a resource- and energy-saving molded product. The company was founded in 1950 and is headquartered in Tokyo, Japan.
Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 382.28B | 388.61B | 361.73B | 301.96B | 321.97B | 337.50B | 332.68B | 287.62B | 295.65B | 307.52B | 296.43B | 250.76B | 262.84B | 270.38B | 225.88B | 268.86B | 302.93B | 281.61B | 263.07B | 231.36B |
Cost of Revenue | 279.77B | 279.20B | 241.53B | 204.52B | 230.23B | 240.93B | 231.72B | 201.05B | 208.81B | 224.89B | 213.31B | 180.62B | 186.30B | 192.69B | 175.83B | 220.58B | 228.83B | 203.16B | 193.22B | 170.69B |
Gross Profit | 102.51B | 109.41B | 120.21B | 97.44B | 91.74B | 96.57B | 100.97B | 86.57B | 86.84B | 82.64B | 83.12B | 70.14B | 76.55B | 77.69B | 50.05B | 48.28B | 74.10B | 78.45B | 69.86B | 60.67B |
Gross Profit Ratio | 26.82% | 28.15% | 33.23% | 32.27% | 28.49% | 28.61% | 30.35% | 30.10% | 29.37% | 26.87% | 28.04% | 27.97% | 29.12% | 28.73% | 22.16% | 17.96% | 24.46% | 27.86% | 26.55% | 26.22% |
Research & Development | 18.23B | 17.58B | 15.87B | 14.26B | 15.27B | 16.48B | 15.10B | 13.23B | 14.15B | 13.63B | 1.26B | 11.90B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 51.01B | 45.43B | 41.62B | 38.85B | 40.51B | 36.25B | 37.32B | 34.10B | 34.08B | 31.73B | 31.99B | 27.65B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Selling & Marketing | 12.77B | 19.45B | 18.44B | 11.04B | 10.03B | 10.87B | 9.97B | 8.83B | 9.11B | 9.03B | 8.56B | 6.90B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 63.78B | 64.88B | 60.06B | 49.89B | 50.53B | 47.12B | 47.29B | 42.93B | 43.18B | 40.76B | 40.56B | 34.55B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Expenses | 0.00 | 498.00M | 691.00M | 1.95B | 485.00M | 746.00M | 319.00M | 734.00M | 935.00M | 1.92B | 165.00M | 750.00M | 126.00M | 778.00M | 1.25B | 4.05B | -1.62B | 316.00M | -266.00M | 93.00M |
Operating Expenses | 82.01B | 82.46B | 75.93B | 64.14B | 65.81B | 63.60B | 62.39B | 56.16B | 57.33B | 54.39B | 53.22B | 46.44B | 44.42B | 42.40B | 40.73B | 45.34B | 48.83B | 48.27B | 43.02B | 41.37B |
Cost & Expenses | 361.78B | 361.67B | 317.45B | 268.66B | 296.03B | 304.53B | 294.11B | 257.21B | 266.14B | 279.28B | 266.53B | 227.07B | 230.72B | 235.09B | 216.56B | 265.92B | 277.66B | 251.44B | 236.24B | 212.06B |
Interest Income | 289.00M | 210.00M | 295.00M | 126.00M | 165.00M | 146.00M | 120.00M | 123.00M | 123.00M | 131.00M | 100.00M | 104.00M | 110.00M | 83.00M | 101.00M | 199.00M | 270.00M | 234.00M | 181.00M | 129.00M |
Interest Expense | 68.00M | 85.00M | 130.00M | 137.00M | 139.00M | 200.00M | 323.00M | 455.00M | 617.00M | 721.00M | 724.00M | 934.00M | 1.04B | 1.15B | 1.29B | 1.64B | 1.47B | 1.08B | 621.00M | 642.00M |
Depreciation & Amortization | 20.12B | 20.38B | 21.47B | 18.15B | 17.45B | 18.82B | 21.21B | 21.10B | 21.57B | 20.11B | 17.70B | 18.12B | 19.89B | 21.13B | 22.26B | 22.60B | 19.50B | 16.25B | 13.52B | 12.88B |
EBITDA | 64.04B | 47.33B | 65.75B | 51.45B | 43.38B | 51.79B | 59.78B | 51.51B | 51.08B | 50.62B | 50.95B | 42.48B | 52.33B | 55.89B | 31.49B | 25.49B | 39.14B | 47.12B | 40.59B | 32.33B |
EBITDA Ratio | 16.75% | 12.18% | 18.18% | 17.04% | 13.47% | 15.35% | 17.97% | 17.91% | 17.28% | 17.06% | 17.25% | 18.00% | 20.11% | 20.67% | 14.60% | 10.45% | 13.73% | 16.73% | 15.43% | 13.97% |
Operating Income | 20.50B | 26.95B | 44.28B | 33.30B | 25.93B | 32.97B | 38.57B | 30.41B | 29.51B | 28.25B | 29.90B | 23.70B | 32.12B | 34.77B | 10.73B | 5.49B | 22.11B | 30.88B | 27.08B | 19.45B |
Operating Income Ratio | 5.36% | 6.93% | 12.24% | 11.03% | 8.05% | 9.77% | 11.59% | 10.57% | 9.98% | 9.18% | 10.09% | 9.45% | 12.22% | 12.86% | 4.75% | 2.04% | 7.30% | 10.96% | 10.29% | 8.40% |
Total Other Income/Expenses | 23.35B | -12.71B | 1.79B | 4.75B | 1.38B | -6.10B | -13.72B | 161.00M | -3.59B | 1.55B | 2.63B | -273.00M | -719.00M | -5.05B | -1.37B | -1.69B | -7.10B | -2.05B | -2.73B | -5.78B |
Income Before Tax | 43.85B | 14.47B | 46.23B | 38.16B | 27.48B | 27.04B | 24.85B | 30.93B | 26.27B | 29.79B | 32.53B | 23.42B | 31.40B | 30.24B | 7.95B | 1.25B | 18.17B | 28.13B | 24.10B | 13.52B |
Income Before Tax Ratio | 11.47% | 3.72% | 12.78% | 12.64% | 8.54% | 8.01% | 7.47% | 10.75% | 8.88% | 9.69% | 10.97% | 9.34% | 11.95% | 11.19% | 3.52% | 0.46% | 6.00% | 9.99% | 9.16% | 5.85% |
Income Tax Expense | 12.85B | 3.86B | 12.52B | 10.28B | 7.13B | 8.25B | 11.40B | 7.16B | 7.43B | 10.38B | 12.54B | 8.26B | 11.59B | 11.32B | 2.73B | -1.35B | 8.63B | 10.50B | 8.36B | 5.47B |
Net Income | 31.10B | 10.57B | 33.41B | 27.72B | 20.20B | 18.46B | 13.06B | 23.15B | 18.08B | 19.08B | 19.65B | 14.75B | 19.13B | 18.30B | 5.02B | 2.48B | 9.09B | 17.08B | 15.25B | 7.77B |
Net Income Ratio | 8.14% | 2.72% | 9.24% | 9.18% | 6.27% | 5.47% | 3.92% | 8.05% | 6.12% | 6.20% | 6.63% | 5.88% | 7.28% | 6.77% | 2.22% | 0.92% | 3.00% | 6.06% | 5.80% | 3.36% |
EPS | 147.12 | 49.94 | 153.23 | 126.74 | 92.44 | 84.06 | 58.81 | 104.31 | 79.86 | 84.13 | 85.15 | 63.81 | 82.75 | 78.77 | 21.26 | 10.50 | 38.24 | 71.74 | 63.23 | 32.01 |
EPS Diluted | 147.12 | 49.92 | 153.12 | 126.63 | 92.30 | 83.94 | 58.73 | 104.17 | 79.74 | 83.98 | 85.01 | 63.70 | 82.63 | 78.65 | 21.24 | 10.49 | 38.22 | 71.72 | 63.23 | 32.01 |
Weighted Avg Shares Out | 211.40M | 211.63M | 218.06M | 218.68M | 218.54M | 219.58M | 222.01M | 221.96M | 226.39M | 226.79M | 230.76M | 231.16M | 231.15M | 232.36M | 236.11M | 236.06M | 237.76M | 238.03M | 239.58M | 241.13M |
Weighted Avg Shares Out (Dil) | 211.40M | 211.74M | 218.21M | 218.88M | 218.87M | 219.91M | 222.31M | 222.25M | 226.73M | 227.20M | 231.15M | 231.55M | 231.48M | 232.71M | 236.35M | 236.22M | 237.89M | 238.11M | 239.58M | 241.13M |
Source: https://incomestatements.info
Category: Stock Reports